ZPHC Tirzepatide 25mg
ALSO KNOWN AS
- Mounjaro
- Twincretin
- GLP-1/GIP Dual Agonist
DESCRIPTION
ZPHC Tirzepatide 25mg is a synthetic dual agonist of GLP-1 and GIP receptors, offering an advanced peptide-based solution for weight loss and blood sugar management. Originally developed for type 2 diabetes, it has gained popularity for its profound fat-reducing and appetite-suppressing effects. Tirzepatide improves insulin sensitivity, reduces food cravings, and enhances metabolic health. Its once-weekly dosing makes it convenient for long-term body composition and weight regulation.
DOSAGE & ADMINISTRATION
- Dosage: 5mg per vial (5 vials per kit = 25mg total)
- Typical Weekly Dose:
- Start at 2.5mg/week
- Titrate up to 5mg or 10mg/week based on tolerance
- Injection: Subcutaneous, once weekly
- Reconstitute with bacteriostatic water and refrigerate after mixing
CYCLE USE
Tirzepatide is used in extended fat-loss or glucose-control programs. It may be combined with compounds like Semaglutide, HGH, or anabolic agents depending on physique goals. It supports consistent fat reduction, appetite suppression, and glycemic balance over a 12–24 week cycle.
PACKAGE CONTENTS
5 vials x 5mg (25mg total)
STORAGE INSTRUCTIONS
- Store below 25°C before reconstitution
- Refrigerate at 2–8°C after mixing
- Use within 14 days post-reconstitution
- Do not freeze
